TickerGuard
Buy Day today: Poor (44) Weak market breadth · major macro event coming up
STRO

Sutro Biopharma

Healthcare · Biotechnology

15.70$ -2.5% vs. previous close Closing price · As of: Sep 23, 2026

Statements

Balance Sheet

Sutro Biopharma (STRO) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 194 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet STRO
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
432 471 403 489 452 387 321 262 210 174 242 194
381 422 355 443 406 343 287 232 182 151 221 176
82 69 65 91 175 190 106 64 66 58 74 54
355 376 313 426 388 317 249 205 168 141 203 164
17 36 31 7.0 6.7 8.6 14 8.0 3.9 4.0 12 5.8
0.0 0.0 0.0
319 321 305 337 341 343 347 294 297 306 309 298
74 94 80 130 131 132 133 74 72 75 71 53
13 10 6.7 6.9 7.2 7.5 7.8 8.1 8.0 7.8 7.6 6.7
5.5 9.4 7.5 6.1 6.2 10 8.2 4.3 7.0 7.6 5.5 3.4
112 150 98 152 111 45 -26 -32 -87 -132 -67 -103
-590 -559 -618 -666 -714 -787 -863 -874 -931 -978 -1,016 -1,055
6.1 6.1 6.1 8.1 8.2 8.3 8.3 8.5 8.5 8.6 13 17

Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?